Short

$VRX - Possible downfall, acqusition of $AGN not done

Due to worse than expected ER, and lowered guidance, and top of all failed AGN acquisition, it is very possible that VVRX is going to $90-$100 price level. Company is not profitable and even if their international profits rise (mostly Russia and Europe), there are problems in creating sustainable growth.
AGNEarningsguidancelowerpharmaceuticalsshortvaleantVRX

Disclaimer